S.Amdt. 282
What it does: Adds SEC. ___. DEVELOPMENT OF BEST PRESCRIBING PRACTICES wherever appropriateWhat it changes
1 change to S. 178
Adds SEC. ___. DEVELOPMENT OF BEST PRESCRIBING PRACTICES wherever appropriate
Adds a sectionInserted: SEC. ___. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.
Inserted: (a) Inter-agency Task Force.--Not later than 120 days after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the "Secretary"), in cooperation with the Secretary of Veterans Affairs, the Secretary of Defense, and the Administrator of the Drug Enforcement Administration, shall convene a Pain Management Best Practices Inter-Agency Task Force (referred to in this section as the "task force").
Inserted: (b) Membership.--The task force shall be comprised of--
Inserted: (1) representatives of--
Inserted: (A) the Department of Health and Human Services;
Inserted: (B) the Department of Veterans Affairs;
Inserted: (C) the Department of Defense;
Inserted: (D) the Drug Enforcement Administration;
Inserted: (E) the Centers for Disease Control and Prevention;
Inserted: (F) the Office of National Drug Control Policy;
Inserted: (G) the Institute of Medicine;
Inserted: (H) pain management professional organizations;
Show 20 more inserted paragraphsShow less
Inserted: (I) the mental health treatment community;
Inserted: (J) the addiction treatment community; and
Inserted: (K) pain advocacy groups;
Inserted: (2) the Director of the National Institutes of Health;
Inserted: (3) physicians, dentists, and non-physician prescribers;
Inserted: (4) pharmacists;
Inserted: (5) experts in the fields of pain research and addiction research; and
Inserted: (6) other stakeholders, as the Secretary determines appropriate.
Inserted: (c) Duties.--The task force shall--
Inserted: (1) not later than 180 days after the date on which the task force is convened, develop best practices for pain management and prescription pain medication prescribing practices, taking into consideration--
Inserted: (A) existing pain management research;
Inserted: (B) recommendations from relevant conferences; and
Inserted: (C) ongoing efforts at the State and local levels and by medical professional organizations to develop improved pain management strategies;
Inserted: (2) solicit and take into consideration public comment on the practices developed under paragraph (1), amending such best practices if appropriate; and
Inserted: (3) develop a strategy for disseminating information about the best practices developed under paragraphs (1) and (2) to prescribers, pharmacists, State medical boards, and other parties, as the Secretary determines appropriate.
Inserted: (d) Limitation.--The task force shall not have rulemaking authority.
Inserted: (e) Report.--Not later than 270 days after the date on which the task force is convened, the task force shall submit to Congress a report that includes--
Inserted: (1) the strategy for disseminating best practices developed under subsection (c);
Inserted: (2) the results of a feasibility study on linking best practices developed under paragraphs (1) and (2) of subsection (c) to receiving and renewing registrations under section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f)); and
Inserted: (3) recommendations on how to apply such best practices to improve prescribing practices at medical facilities, including medical facilities of the Veterans Health Administration.
The amendment doesn't say where this goes; the clerk decides.
Original wording
At the appropriate place, insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 282. Ms. AYOTTE (for herself and Mr. Donnelly) submitted an amendment intended to be proposed by her to the bill S. 178, to provide justice for the victims of trafficking; which was ordered to lie on the table; as follows:
At the appropriate place, insert the following:
SEC. ___. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.
(a) Inter-agency Task Force.--Not later than 120 days after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”), in cooperation with the Secretary of Veterans Affairs, the Secretary of Defense, and the Administrator of the Drug Enforcement Administration, shall convene a Pain Management Best Practices Inter-Agency Task Force (referred to in this section as the “task force”).
(b) Membership.--The task force shall be comprised of--
(1) representatives of--
(A) the Department of Health and Human Services;
(B) the Department of Veterans Affairs;
(C) the Department of Defense;
(D) the Drug Enforcement Administration;
(E) the Centers for Disease Control and Prevention;
(F) the Office of National Drug Control Policy;
(G) the Institute of Medicine;
(H) pain management professional organizations;
(I) the mental health treatment community;
(J) the addiction treatment community; and
(K) pain advocacy groups;
(2) the Director of the National Institutes of Health;
(3) physicians, dentists, and non-physician prescribers;
(4) pharmacists;
(5) experts in the fields of pain research and addiction research; and
(6) other stakeholders, as the Secretary determines appropriate.
(c) Duties.--The task force shall--
(1) not later than 180 days after the date on which the task force is convened, develop best practices for pain management and prescription pain medication prescribing practices, taking into consideration--
(A) existing pain management research;
(B) recommendations from relevant conferences; and
(C) ongoing efforts at the State and local levels and by medical professional organizations to develop improved pain management strategies;
(2) solicit and take into consideration public comment on the practices developed under paragraph (1), amending such best practices if appropriate; and
(3) develop a strategy for disseminating information about the best practices developed under paragraphs (1) and (2) to prescribers, pharmacists, State medical boards, and other parties, as the Secretary determines appropriate.
(d) Limitation.--The task force shall not have rulemaking authority.
(e) Report.--Not later than 270 days after the date on which the task force is convened, the task force shall submit to Congress a report that includes--
(1) the strategy for disseminating best practices developed under subsection (c);
(2) the results of a feasibility study on linking best practices developed under paragraphs (1) and (2) of subsection (c) to receiving and renewing registrations under section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f)); and
(3) recommendations on how to apply such best practices to improve prescribing practices at medical facilities, including medical facilities of the Veterans Health Administration.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
March 10, 2015
View full timeline
Senate amendment submitted
March 10, 2015
Senate amendment submitted
March 10, 2015